台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.49%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-第一金-光復 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-光復 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/14298.001.298.54102.000.81440.55%
2024/05/1300.001.2107.00107.00-1.2127-0.94%
2024/05/100.1119.0000.00118.500.11200.08%
2024/05/090.1119.5000.00118.500.11190.08%
2024/05/070.1119.5000.00119.500.11190.08%
2024/05/060.1119.5000.00119.000.11180.10%
2024/05/030.1118.5000.00118.500.11170.09%
2024/05/020.1118.0000.00118.000.11160.04%
2024/04/300.2117.5000.00118.000.21160.17%
2024/04/290.1117.5000.00117.500.11160.09%
2024/04/250.2118.0000.00117.500.21150.17%
2024/04/230.1117.5000.00117.500.11150.09%
2024/04/1600.000.9114.00114.00-0.9111-0.81%
2024/04/1500.000.3117.50117.00-0.3107-0.30%
2024/04/0300.000.3123.00123.50-0.371-0.39%
2024/03/2700.000.3122.00122.00-0.366-0.45%
2024/03/2100.000.2122.50121.50-0.258-0.34%
2024/03/1400.000.2119.50119.00-0.243-0.46%
2024/03/060.1113.5000.00113.500.1340.29%
2024/03/0500.000.1113.00113.50-0.133-0.39%
2024/02/1900.001112.50113.00-131-3.18%
2024/01/310.1111.5000.00111.500.1310.32%
2023/12/280.2115.5000.00115.000.2240.78%
2023/12/250.2114.0000.00114.500.2240.63%
2023/12/210.1114.5000.00114.000.1230.25%
2023/12/070.2114.0000.00114.500.2210.71%
2023/12/050.1114.0000.00114.000.1210.46%
2023/11/280.1114.0000.00114.000.1200.48%
2023/11/1000.001114.00113.50-120-4.91%
2023/11/0900.000.1115.50115.00-0.120-0.50%
2023/10/310.1115.5000.00115.000.1200.63%
2023/10/2000.000.1117.00117.00-0.123-0.33%
2023/10/1200.000.2116.50117.00-0.225-0.79%
2023/09/150.1115.0000.00114.000.1260.45%
2023/09/140.1114.5000.00114.500.1260.49%
2023/09/060.1111.5000.00112.000.1280.35%
2023/08/280.1111.5000.00110.500.1300.33%
2023/08/220.1110.5000.00110.000.1310.32%
2023/08/090.1112.5000.00111.500.1290.33%
2023/07/3100.000.3113.70111.50-0.333-0.75%
2023/07/190.3108.5000.00108.000.3291.02%
2023/07/140.2108.5000.00108.500.2300.53%
2023/06/290.1108.5000.00108.500.1460.30%
2023/06/280.2108.5000.00108.000.2470.42%
2023/06/260.1108.0000.00108.000.1510.20%
2023/06/200.1108.5000.00108.000.1520.19%
2023/06/190.1108.5000.00108.000.1550.09%
2023/06/050.1109.0000.00108.000.1550.14%
2023/06/010.1108.0000.00108.500.1550.14%
2023/05/310108.5000.00108.000550.08%
2023/05/240.1109.0000.00109.000.1560.26%
2023/05/220.1109.0000.00109.000.1560.18%
2023/05/150.1108.0000.00107.500.1550.18%
2023/05/110.1107.5000.00106.500.1550.18%
2023/04/280.2109.0000.00109.500.2520.36%
2023/04/270.1108.5000.00108.000.1520.19%
2023/04/260108.5000.00108.500530.06%
2023/04/240.1109.0000.00109.000.1530.15%
2023/04/170.1111.0000.00109.500.1510.10%
2023/04/140.1111.0000.00111.000.1500.26%
2023/04/130.1118.5000.00119.500.1470.21%
2023/04/1200.000.7119.00119.00-0.742-1.53%
2023/04/110.1121.0000.00121.000.1400.25%
2023/04/100.1121.0000.00120.500.1390.13%
2023/04/070120.5000.00119.500360.05%
2023/03/280.1118.5000.00117.500.1340.23%
2023/03/220.1115.5000.00115.500.1290.34%
2023/03/170.1112.5000.00112.000.1260.38%
2023/03/150.1113.5000.00113.000.1300.16%
2023/03/010.2109.5000.00109.000.2350.56%
2022/09/2600.001.1105.98105.00-1.116-6.36%
2022/08/251111.5000.00111.501204.92%
2022/08/021110.5000.00111.001442.27%
2022/07/180.1106.2500.00107.000.1420.24%
2021/07/051152.5000.00153.501392.53%
2021/05/112148.2500.00146.502414.77%
2018/11/2300.001104.00104.50-129-3.44%
2018/11/061105.0000.00106.001293.39%
2018/05/1000.001128.50128.50-1127-0.79%
2018/05/091129.0000.00129.0011270.79%
2018/05/0400.001129.50128.50-1117-0.85%
2018/04/2700.001120.50124.00-1117-0.85%
2018/04/201123.5000.00124.0011520.66%
2018/04/0200.001131.00129.50-1162-0.62%
2018/03/301129.5000.00129.5011610.62%
2018/03/2300.001123.50124.00-1166-0.60%
2018/03/221126.0000.00125.5011700.59%
2018/03/2100.001131.00128.50-1183-0.54%
2018/03/201128.5000.00127.5011780.56%
2018/03/0200.001121.50120.00-1175-0.57%
2018/02/082115.5000.00116.0021651.21%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音